[1]刘高雯,段 颖.急性缺血性脑卒中小鼠模型脑组织中miR-21 表达对炎症反应和细胞凋亡的影响及相关机制研究[J].现代检验医学杂志,2023,38(03):86-91+96.[doi:10.3969/j.issn.1671-7414.2023.03.015]
 LIU Gao-wen,DUAN Ying.Effects of miR-21 Expression on Inflammatory Response and Apoptosis in Brain Tissue of Mice with Acute Ischemic Stroke and Related Mechanisms[J].Journal of Modern Laboratory Medicine,2023,38(03):86-91+96.[doi:10.3969/j.issn.1671-7414.2023.03.015]
点击复制

急性缺血性脑卒中小鼠模型脑组织中miR-21 表达对炎症反应和细胞凋亡的影响及相关机制研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年03期
页码:
86-91+96
栏目:
论著
出版日期:
2023-05-15

文章信息/Info

Title:
Effects of miR-21 Expression on Inflammatory Response and Apoptosis in Brain Tissue of Mice with Acute Ischemic Stroke and Related Mechanisms
文章编号:
1671-7414(2023)03-086-07
作者:
刘高雯段 颖
(咸阳市中心医院重症医学科,陕西咸阳 712000)
Author(s):
LIU Gao-wen DUAN Ying
(Department of Critical Care Medicine,Xianyang Central Hospital, Shaanxi Xianyang 712000,China)
关键词:
微小核糖核酸-21急性缺血性脑卒中炎症反应细胞凋亡
分类号:
R743.33;R-332
DOI:
10.3969/j.issn.1671-7414.2023.03.015
文献标志码:
A
摘要:
目的 研究急性缺血性脑卒中(acute ischemic stroke, AIS)小鼠模型脑组织中miR-21 表达对炎症反应和细胞凋亡的影响,并探讨其相关分子机制。方法 选取C57/BL6 小鼠30 只随机均分为假手术组、短暂局灶性大脑中动脉闭塞(tran-sient middle cerebral artery occlusion,tMCAO)模型组(利用线栓法构建短暂局灶性大脑中动脉闭塞小鼠模型)及miR-21 agomir 激动剂预处理组(tMCAO 术后侧脑室注射miR-21 agomir 激动剂)。RT-PCR 法检测小鼠脑组织中miR-21 表达水平;改良神经严重程度评分(modified neurological severityscore,mNSS)评估小鼠神经功能;2,3,5-三苯基氯化四氮唑(2,3,5-Triphenyltetrazolium chloride,TTC)染色法检测小鼠脑梗死体积;酶联免疫吸附法检测炎症因子(TGF-β1,TNF-α,IL-18 和IL-10)水平变化;原位末端标记(terminal-deoxynucleoitidyl transferase mediatednick end labeling,Tunel)法观察小鼠神经细胞凋亡情况;蛋白免疫印迹法检测TLR4/NF-κB/NLRP3 通路相关蛋白及凋亡蛋白(Bcl-2/Bax)表达情况。结果 假手术组﹑ tMCAO 模型组和miR-21 agomir 组小鼠脑组织中miR-21 表达水平分别为0.83±0.17,0.50±0.11 和1.55±0.32,组间差异有统计学意义(F=43.805,P<0.05)。假手术组小鼠神经功能mNSS 评分均为0 分,tMCAO 组mNSS 评分明显高于miR-21 agomir 组(11.30±3.42 vs 5.61±1.73),差异有统计学意义(t=12.784,P<0.05)。假手术组小鼠脑组织未出现梗死现象,tMCAO 组脑梗死体积(62.72%±5.30%)高于miR-21 agomir 组(38.22%±3.31%),差异有统计学意义(t=31.309,P<0.05)。与tMCAO 组比较,miR-21 过表达明显降低促炎因子TNF-α 和IL-18 水平,升高抗炎因子TGF-β1 和IL-10 水平,差异均有统计学意义(t=3.785 ~ 9.693,均P<0.05)。假手术组脑组织皮层细胞凋亡数约为9.40±5.21 个,明显低于 tMCAO 组的75.52±12.81 个,差异有统计学意义(t=38.552,P<0.05);miR-21 agomir 组细胞凋亡数约为42.41±9.62 个,低于tMCAO 组,差异有统计学意义(t=19.174,P<0.05)。与tMCAO 组比较,miR-21 过表达组小鼠脑组织中TLR4, NF-κB,p-NF-κB 和NLRP3 蛋白表达降低,Bcl-2/Bax 表达升高,差异均有统计学意义(t=2.314 ~ 3.098,均P < 0.05)。结论 miR-21 在急性缺血性脑卒中后小鼠脑组织中表达明显下降,其过表达可以调节脑缺血后促炎因子和抗炎因子之间的平衡,改善皮层细胞凋亡,可能是通过调控TLR4/NF-κB/NLRP3 通路发挥脑损伤保护作用。
Abstract:
Objective To study the effect of miR-21 expression on inflammatory response and apoptosis in the brain tissue of acute ischemic stroke(AIS) mice, and explore its related molecular mechanism. Methods Thirty C57/BL6 mice were randomly divided into sham operation group, transient middle cerebral artery occlusion(tMCAO) model group (a mouse model of transient focal middle cerebral artery occlusion was established by thread embolism method) and miR-21 agonist pretreatment group (miR-21 agonist was injected into cerebral ventricle after tMCAO operation). The expression of miR-21 in mouse brain was detected by RT-PCR,modified neural severity score (mNSS) was used to evaluate the neural function of mice, 2,3,5-Triphenyltetrazolium chloride (TTC) staining was used to detect the volume of cerebral infarction in mice. Detected inflammatory factors (TGF)-β1,TNF-α,IL-18 and IL-10 level change by enzyme-linked immunosorbent assay. Terminaldeoxynucleoitidyl transferase mediated nick end labeling(Tunel) method was used to observe the neuronal apoptosis in mice, and detected TLR4/NF by Western blot- κ Expression of B/NLRP3 pathway related protein and apoptosis protein (Bcl-2/Bax). Results The expression levels of miR-21 in brain tissues of sham operation group, tMCAO model group and miR-21 agomir group were 0.83 ± 0.17,0.50 ± 0.11 and 1.55 ± 0.32, respectively, with significant difference between groups (F=43.805,P<0.05). The mNSS score of neural function in sham operation group was 0,the mNSS score in the tMCAO group was significantly higher than that in the miR-21 agomir group (11.30 ± 3.42 vs 5.61 ± 1.73), with a statistically significant difference (t=12.784, P<0.05). There was no cerebral infarction in sham operation group,the infarct volume in tMCAO group was about 62.72% ± 5.30%, and that in miR-21 agomir group was about 38.22% ± 3.31%,and the difference was statistically significant (t=31.309, P<0.05). Compared with tMCAO group, overexpression of miR-21 significantly reduced proinflammatory factor TNF- α and IL-18 levels, increasing the anti-inflammatory factor TGF-β1 and IL-10 levels, and the differences were statistically significant (t=3.785 ~ 9.693, all P<0.05). The number of apoptotic cortical cells in sham operation group was about 9.40 ± 5.21, which was significantly lower than that in tMCAO group 75.52 ± 12.81,the difference was statistically significant (t=38.552, P<0.05). The number of apoptosis in miR-21 agomir group was about 42.41 ± 9.62, which was lower than that in tMCAO group, the difference was statistically significant (t=19.174, P<0.05). Compared with tMCAO group, TLR4,NF-κB, p-NF-κB and NLRP3 decreased in brain tissue of miR-21 overexpression group, the expression of Bcl-2/Bax increased, and the differences were statistically significant (t=2.314 ~ 3.098, all P<0.05). Conclusion The expression of miR-21 in the brain tissue of mice after acute ischemic stroke decreased significantly. Its overexpression can regulate the balance between proinflammatory factors and anti-inflammatory factors after cerebral ischemia, and improve the apoptosis of cortical cells, possibly by regulating TLR4/ NF- κ B/NLRP3 pathway plays a protective role in brain injury.

参考文献/References:

[1] HATHIDARA M Y, SAINI V, MALIK A M. Stroke in the young: A global update[J]. Current Neurology and Neuroscience Reports, 2019, 19(11): 91.
[2] 申青仙, 张赛, 涂悦, 等, 急性缺血性脑卒中的临床 治疗研究进展[J]. 中国医药, 2020, 15(4): 633-636. SHEN Qingxian, ZHANG Sai, TU Yue, et al. Research progress in clinical treatment of acute ischemic stroke[J]. China Medicine, 2020, 15(4): 633-636.
[3] RABINSTEIN A A. Update on treatment of acute ischemic stroke[J]. Continuum (Minneapolis, Minn.),2020, 26(2): 268-286.
[4] JAYARAJ R L, AZIMULLAH S, BEIRAM R, et al. Neuroinflammation: Friend and foe for ischemic stroke[J]. Journal of Neuroinflammation, 2019, 16(1): 142.
[5] LOPEZ M S, MORRIS-BLANCO K C, LY N, et al. MicroRNA miR-21 decreases post-stroke brain damage in rodents[J]. Translational Stroke Research, 2022,13(3): 483-493.
[6] JIN Xin, LIU Mingyan, ZHANG Dongfang, et al. Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/ NF-κB signaling pathway[J]. CNS Neuroscience & Therapeutics, 2019, 25(5): 575-590.
[7] 中国中西医结合学会急救医学专业委员会, 方邦江,李志军, 等. 中国急性缺血性脑卒中中西医急诊诊 治专家共识[J]. 中华危重病急救医学, 2018, 30(3): 193-197,Chinese Society for Integrated Chinese and Western Medicine First Aid Medicine Specialized Committee,FANG Bangjiang, LI Zhijun, et al. Expert consensus of Chinese and Western medicine emergency treatment for acute ischemic stroke in China[J]. Chinese Critical Care Medicine , 2018, 30(3): 193-197.
[8] 班俊杰, 黄丽娜. 外泌体miRNA 在缺血性脑血管病 中作用的研究进展[J]. 中华实用诊断与治疗杂志,2019, 33(3): 295-298. BAN Junjie, HUANG Lina. Role of exosomal microRNA in ischemic cerebrovascular disease[J]. Journal of Chinese Practical Diagnosis and Therapy,2019, 33(3): 295-298.
[9] 文全庆, 贾延劼, 王明闯, 等. 大鼠脑缺血急性期 脑组织miRNA 的表达变化[J]. 重庆医科大学学报,2008, 33(Z1): 23-26, 40. WEN Quanqing, JIA Yanjie, WANG Mingchuang, et al. Expression analysis of microRNA on acute cerebral ischemia in rats[J]. Journal of Chongqing Medical University, 2008, 33(Z1): 23-26, 40.
[10] 高法梁, 娄远蕾, 阮琼芳, 等. 缺血性脑损伤大鼠 MicroRNA 210 的动态变化[J]. 实验与检验医学,2010, 28(3): 230-232. GAO Faliang, LOU Yuanlei, RUAN Qiongfang, et al. Dynamic changes of miR-210 after brain stroke in rats[J]. Experimental and Laboratory Medicine, 2010,28(3): 230-232.
[11] 郭洁, 池水侠. 急性缺血性脑卒中患者血清miRNA- 181c-5p, miRNA-340-5p 和miRNA146a 水平表达 检测的诊断价值研究[J]. 现代检验医学杂志, 2021,36(5): 43-45, 89. GUO Jie, CHI Shuixia. Diagnostic value of miRNA- 181c-5p, miRNA-340-5p and miRNA146a levels in patients with acute ischemic stroke[J]. Journal of Modern Laboratory Medicine, 2021, 36(5): 43-45, 89.
[12] KALAYINIA S, ARJMAND F, MALEKI M, et al. MicroRNAs: roles in cardiovascular development and disease[J]. Cardiovasc Pathol, 2021, 50:107296.
[13] HUANG C K, B?R C, THUM T. MiR-21, mediator,and potential therapeutic target in the cardiorenal syndrome[J]. Frontiers in Pharmacology, 2020, 11: 726.
[14] TU Qiulin, LE Dongsheng, WANG Chengyun, et al. Pterostilbene attenuates ischemic stroke by modulating miR-21-5p/PDCD4 axis in vivo and in vitro[J]. Journal of Functional Foods, 2020, 75: 104275.
[15] YAO Xiaofeng, WANG Yahui, ZHANG Dongya. MicroRNA-21 confers neuroprotection against cerebral Ischemia-Reperfusion injury and alleviates Blood- Brain barrier disruption in rats via the MAPK signaling pathway[J]. Journal of Molecular Neuroscience, 2018,65(1): 43-53.
[16] YAN Honglin, HUANG Wenxian, RAO Jie, et al. MiR- 21 regulates ischemic neuronal injury via the p53/ Bcl-2/Bax signaling pathway[J]. Aging, 2021, 13(18): 22242-22255.
[17] 杜佳琳, 龚诗立, 胡朝英, 等, 缺血性脑卒中的神经 炎症反应机制及相关的抗炎药物研究进展[J]. 药物 评价研究, 2022, 45(10): 2126-2132. DU Jialin, GONG Shili, HU Chaoying, et al. Progress of neuroinflammation and anti-inflammatory drugs of ischemic stroke[J]. Drug Evaluation Research, 2022,45(10): 2126-2132.
[18] 孙婷婷, 张佩兰. 青年缺血性脑卒中的病因及发病 机制研究进展[J]. 中国实用神经疾病杂志, 2018,21(4): 447-449. SUN Tingting, ZHANG Peilan. Research progress on etiology and pathogenesis of ischemic stroke in young People[J]. Chinese Journal of Practical Nervous Diseases, 2018, 21(4): 447-449.
[19] 苏钰, 朱文浩. 炎性小体与缺血性脑卒中发病及中 医相关机制的研究进展[J]. 中西医结合心脑血管病 杂志, 2022, 20(19): 3582-3586. SU Yu, ZHU Wenhao. Research progress on inflammatory bodies,ischemic stroke and TCM related mechanisms[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease, 2022,20(19): 3582-3586.
[20] ZHOU Wei, SU Li, DUAN Xingyu, et al. MicroRNA- 21 down-regulates inflammation and inhibits periodontitis[ J]. Molecular Immunology, 2018, 101: 608- 614.
[21] LUO Man, YAN Dongsheng, SUN Qingsong, et al. Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF-kB/NLRP3 pathway[J]. Journal of Cellular Biochemistry, 2020,121(4): 2994-3004.
[22] LI Yuping, LIANG Wenyi, GUO Caijuan, et al. Renshen shouwu extract enhances neurogenesis and angiogenesis via inhibition of TLR4/NF-κB/NLRP3 signaling pathway following ischemic stroke in rats[J]. Journal of Ethnopharmacology, 2020, 253: 112616.
[23] BAI Yejun, LI Zhigang, LIU Weihao, et al. Biochanin a attenuates myocardial ischemia/reperfusion injury through the TLR4/NF-κB/NLRP3 signaling pathway[J]. Acta Cirurgica Brasileira, 2019, 34(11): e201901104.
[24] SUN Zhezhe, NYANZU M, YANG Su, et al. VX765 attenuates pyroptosis and HMGB1/TLR4/NF- κ B pathways to improve functional outcomes in TBI mice[J]. Oxidative Medicine and Cellular Longevity,2020, 2020: 7879629.
[25] 王丹姝, 燕柳艳, 孙姝婵, 等. 葛根素通过TLR4/ Myd88/NF-κB 抑制NLRP3 炎症小体抗大鼠心肌缺 血再灌注损伤[J]. 药学学报, 2021, 56(5): 1343-1351. WANG Danshu, YAN Liuyan, SUN Shuchan, et al. Puerarin protects against myocardial ischemia/ reperfusion injury by suppressing NLRP3 inflammasome activation via TLR4/Myd88/NF-κB pathway in rats[J]. Acta Pharmaceutica Sinica, 2021,56(5): 1343-1351.
[26] ZHANG Yan, JIANG Yuliang, LU Dongjie. Diosmetin suppresses neuronal apoptosis and inflammation by modulating the phosphoinositide 3-kinase (PI3K)/AKT/ nuclear factor-κB (NF-κB) signaling pathway in a rat model of pneumococcal meningitis[J]. Med Sci Monit,2019, 25: 2238-2245.
[27] LIU Jie, MA Wei, ZANG Chenghao, et al. Salidroside inhibits NLRP3 inflammasome activation and apoptosis in microglia induced by cerebral ischemia/reperfusion injury by inhibiting the TLR4/NF-κB signaling pathway[J]. Annals of Translational Medicine, 2021,9(22): 1694.
[28] ZHAN Lan, PANG Yu , J I A N G H a o , e t a l . Butylphthalide inhibits TLR4/NF- κ B pathway by upregulation of miR-21 to have the neuroprotective effect[J]. Journal of Healthcare Engineering, 2022,2022: 4687349.

相似文献/References:

[1]国钰梅,马 龙,包成月,等.急性缺血性脑卒中患者尿酸水平与出院结局的关联研究[J].现代检验医学杂志,2015,30(03):17.[doi:10.3969/j.issn.1671-7414.2015.03.005]
 GUO Yu-mei,MA Long,BAO Cheng-yue,et al.Relationship between Uric Acid Levels in Patients with Acute Ischemic Stroke and Discharged Outcome[J].Journal of Modern Laboratory Medicine,2015,30(03):17.[doi:10.3969/j.issn.1671-7414.2015.03.005]
[2]许红霞,宋来春.血栓弹力图动态监测AIS患者瑞通立静脉溶栓过程及其应用[J].现代检验医学杂志,2016,31(05):137.[doi:10.3969/j.issn.1671-7414.2016.05.040]
 XU Hong-xia,SONG Lai-chun.Thromboelastographic Dynamic Monitoring and Clinical Application in Patients Experiencing Acute Ischemic Stroke and Receiving Reteplase[J].Journal of Modern Laboratory Medicine,2016,31(03):137.[doi:10.3969/j.issn.1671-7414.2016.05.040]
[3]郭 洁,池水侠.急性缺血性脑卒中患者血清miRNA-181c-5p,miRNA-340-5p和miRNA146a水平表达检测的诊断价值研究[J].现代检验医学杂志,2021,36(05):43.[doi:10.3969/j.issn.1671-7414.2021.05.009]
 GUO Jie,CHI Shui-xia.Diagnostic Value of miRNA-181c-5p, miRNA-340-5p and miRNA146a Levelsin Patients with Acute Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2021,36(03):43.[doi:10.3969/j.issn.1671-7414.2021.05.009]
[4]张亚杰,王玉琳,董晓娇,等.急性缺血性脑卒中患者血清lncRNASNHG12表达水平检测及临床意义[J].现代检验医学杂志,2022,37(02):121.[doi:10.3969/j.issn.1671-7414.2022.02.025]
 ZHANG Ya-jie,WANG Yu-lin,DONG Xiao-jiao,et al.Detection of Serum lncRNA SNHG12 Expression Level in Patients with Acute Ischemic Stroke and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2022,37(03):121.[doi:10.3969/j.issn.1671-7414.2022.02.025]
[5]姜富祥,阿尔宾,高 飞,等.miR-21 靶向调控PTEN/PI3K/AKT 通路对骨肉瘤细胞增殖、侵袭和凋亡的影响[J].现代检验医学杂志,2022,37(04):18.[doi:10.3969/j.issn.1671-7414.2022.04.004]
 JIANG Fu-xiang,A Er-bin,GAO Fei,et al.EEffect of miR-21 Targeted Regulation of PTEN/PI3K/AKT Pathway on the Proliferation, Invasion and Apoptosis of Osteosarcoma Cells[J].Journal of Modern Laboratory Medicine,2022,37(03):18.[doi:10.3969/j.issn.1671-7414.2022.04.004]
[6]石庆丽,贾嘉琦,李秀艳,等.急性缺血性脑卒中患者血清Hcy,LncRNA CAI2 和ERCC1 表达水平与预测并发认知障碍的价值研究[J].现代检验医学杂志,2022,37(04):53.[doi:10.3969/j.issn.1671-7414.2022.04.011]
 SHI Qing-li,JIA Jia-qi,LI Xiu-yan,et al.Serum Hcy, LncRNA CAI2 and ERCC1 Expression Levels in Patients with Acute Ischemic Stroke and the Value of Predicting Cognitive Impairment[J].Journal of Modern Laboratory Medicine,2022,37(03):53.[doi:10.3969/j.issn.1671-7414.2022.04.011]
[7]李小琴,余广兰.急性缺血性脑卒中患者血清Cav-1 和GDF-15 表达水平及对预后的评估价值研究[J].现代检验医学杂志,2022,37(04):118.[doi:10.3969/j.issn.1671-7414.2022.04.023]
 LI Xiao-qin,YU Guang-lan.Expression Levels of Serum Cav-1 and GDF-15 and Their Prognostic Value in Patients with Acute Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2022,37(03):118.[doi:10.3969/j.issn.1671-7414.2022.04.023]
[8]孙丽坤a,赵凤依a,常玮鑫a,等.急性缺血性脑卒中患者血清lncRNA SOX2OT 和miR-331 水平对不稳定斑块形成和重度神经功能缺损的诊断价值[J].现代检验医学杂志,2022,37(06):76.[doi:10.3969/j.issn.1671-7414.2022.06.014]
 SUN Li-kuna,ZHAO Feng-yia,CHANG Wei-xina,et al.Diagnostic Value of Serum lncRNA SOX2OT, miR-331 Levels in Patients with Acute Ischemic Stroke for Unstable Plaque Formation and Severe Neurological Deficit[J].Journal of Modern Laboratory Medicine,2022,37(03):76.[doi:10.3969/j.issn.1671-7414.2022.06.014]
[9]刘 懿,贺晓婵,王亚荣,等.急性缺血性脑卒中患者血清AIM2 和LTB4 水平表达及与预后的相关性研究[J].现代检验医学杂志,2023,38(04):22.[doi:10.3969/j.issn.1671-7414.2023.04.004]
 LIU Yi,HE Xiaochan,WANG Yarong,et al.Study on the Expression Levels of Serum AIM2 and LTB4 in Patients with Acute Ischemic Stroke and Their Correlation with Prognosis[J].Journal of Modern Laboratory Medicine,2023,38(03):22.[doi:10.3969/j.issn.1671-7414.2023.04.004]
[10]郭继勃a,钟 曌b,郭 昊c,等.急性缺血性脑卒中患者血浆LIPCAR 和MMP-9 水平与病情严重程度及溶栓治疗后认知功能的关系研究[J].现代检验医学杂志,2023,38(05):40.[doi:10.3969/j.issn.1671-7414.2023.05.008]
 GUO Jiboa,ZHONG Zhaob,GUO Haoc,et al.Study on the Relationship between Peripheral Blood LIPCAR, MMP-9 and Severity of Acute Ischemic Stroke and Cognitive Function after RT-PA Intravenous Thrombolysis[J].Journal of Modern Laboratory Medicine,2023,38(03):40.[doi:10.3969/j.issn.1671-7414.2023.05.008]

备注/Memo

备注/Memo:
作者简介:刘高雯(1983-),女,研究生,主治医师,研究方向:神经内科学,E-mail:wendygao 1983@163.com。
更新日期/Last Update: 2023-05-15